Robert Prunetti, President & CEO Performance Health Technologies, Inc. Trenton, NJ 08611 June 21, 2007Performance Health Technologies Inc • August 21st, 2007 • Electromedical & electrotherapeutic apparatus • Florida
PERFORMANCE HEALTH TECHNOLOGIES, INC., a Delaware corporation (the “Seller”), proposes to offer and sell (the “Offering”), to selected investors, upon the terms set forth herein and in the Subscription Agreement and the Confidential Private Placement Memorandum (which collectively, together with the attachments and exhibits thereto, is referred to as the “Offering Document”), a copy of which has been delivered to you, up to $600,000 worth of units (the “Units”) consisting of convertible notes (“Convertible Notes”) and warrants (“Warrants”). Dawson James Securities, Inc. (the “Selling Agent”) agrees to offer and sell the Offered Securities on a non-exclusive “best efforts” basis during the offering period described in the Offering Document (the “Offering Period”). Capitalized terms used and not otherwise defined herein shall have the respective meanings set forth in the Offering Document. It is intended that the offer, offer for sale and sale of the Offered Securities will be made only
THIS WARRANT AND THE SECURITIES ISSUABLE UPON EXERCISE HEREOF HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND MAY NOT BE OFFERED, SOLD, PLEDGED OR OTHERWISE TRANSFERRED OR DISPOSED OF EXCEPT PURSUANT...Performance Health Technologies Inc • August 21st, 2007 • Electromedical & electrotherapeutic apparatus • Delaware
THIS IS TO CERTIFY THAT, for value received, DAWSON JAMES SECURITIES, INC., or its registered assigns (hereinafter referred to as the (“Holder”), is entitled to subscribe and purchase from PERFORMANCE HEALTH TECHNOLOGIES, INC., a Delaware corporation (the “Company”), commencing on the date hereof, 250,000 shares of Common Stock, $.01 par value, of the Company (the “Shares”), at the place where the Warrant Agency (as hereinafter defined) is located, at the Exercise Price (as hereinafter defined), all subject to adjustment and upon the terms and conditions as hereinafter provided, and is entitled also to exercise the other appurtenant rights, powers and privileges hereinafter described; provided, however, that in no event shall the Holder be entitled to exercise this Warrant for a number of Shares in excess of that number of Shares which, upon giving effect to such exercise, would cause the aggregate number of shares of Company Common Stock beneficially owned by the Holder and its affili
